SPONSOR
Federico II University
Total Trials
3
Recruiting
3
Phases
Phase 4
Conditions studied: T2DM (Type 2 Diabetes Mellitus)Glycemic and Insulinemic ResponseType 1 Diabetes (T1D)Ischemia, MyocardialNon-Obstructive Coronary AtherosclerosisMicrocirculatory StatusCoronary Microvascular Dysfunction (CMD)
Federico II University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including T2DM (Type 2 Diabetes Mellitus), Glycemic and Insulinemic Response, Type 1 Diabetes (T1D), Ischemia, Myocardial.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Federico II University
How many clinical trials has Federico II University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Federico II University, of which 3 are actively recruiting participants. These trials cover conditions including T2DM (Type 2 Diabetes Mellitus), Glycemic and Insulinemic Response, Type 1 Diabetes (T1D). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Federico II University research focus on?
Federico II University clinical trials span T2DM (Type 2 Diabetes Mellitus), Glycemic and Insulinemic Response, Type 1 Diabetes (T1D), Ischemia, Myocardial, Non-Obstructive Coronary Atherosclerosis, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Federico II University clinical trial?
To participate in a Federico II University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Federico II University trials with current recruitment status updated daily.
Clinical Trials by Federico II University
NCT07314684 Phase 4
Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
T2DM (Type 2 Diabetes Mellitus)
NCT06994403
Recruiting
Glycemic Response to Carbob-Enriched Pasta in Healthy and With Type 1 Diabetes People
Glycemic and Insulinemic Response
NCT06588244
Recruiting
INOCA-NA a Local Prospective Registry
Ischemia, Myocardial
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology